Clinical Trial

The Efficacy of Antegrade and Retrograde Enemas Management in Low Anterior Resection Syndrome and Improving the Rate of Ileostomy Reversal

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Anterior rectal resection has become the primary surgical treatment for rectal cancer. However, studies have reported that up to 80%-90% of patients who undergo anterior rectal resection experience varying degrees of defecation dysfunction after surgery, such as frequent bowel movements, urgent bowel movements, and faecal incontinence, known as low anterior resection syndrome (LARS). This can lead to a decline in quality of life after surgery and even partial loss of social functioning.
Trial Details
NCT Number NCT07082699
Lead Sponsor Sichuan Cancer Hospital and Research Institute
Conditions LARS - Low Anterior Resection Syndrome
Enrollment 72 participants
Start Date 2025-07-20
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-24